P
Separately, Vertex Pharmaceuticals announced that it has licensed LifeSeq Gold for use in small molecule drug discovery. The drug company will use the genomic information as part of its chemogenomics discovery effort, which seeks to rapidly and simultaneously design multiple lead classes of drugs directed at protein targets in gene families.